Biopsia de próstata fusión

fusion prostate biopsy

Share it

Prostate biopsy with the image fusion method, which integrates ultrasound and magnetic resonance imaging, allows us to identify the exact location of the prostate tumor and in many cases even its nature.

Today it is very common to use PSA as a control method to try to detect prostate cancer early.

As we all know, PSA is a tumor marker, which is why if the PSA value is above normal limits, we are forced to study why it has happened.

Our mission as doctors is above all to be able to diagnose in time those diseases whose evolution can lead to a significant deterioration in the health of our patients.

Referring to prostate cancer, one of the most common in men, this premise becomes absolutely relevant since early detection of cancer can mean saving the patient’s life or at least avoiding serious consequences if it develops.

Until now, in those patients who had an elevated PSA in routine controls, that is, those in whom there is a well-founded suspicion of having prostate cancer, we followed the criteria of first performing an MRI (magnetic resonance imaging) of the prostate.

This test determines with great precision not only the alterations that have been produced within the prostate gland, but also if the tumor has been able to spread outside of it.

But this test in itself is not diagnostic, that is, it does not give us absolute certainty as to whether or not we have prostate cancer, which is why a posteriori and to complete the diagnosis we have to perform a biopsy of the gland.

Until recently, prostate biopsy was done randomly, we could almost say blind.

Therefore, the possibility of failing to detect the prostate tumor was greater than 30%.

You can’t fight what you can’t see

Currently we have in our urology department at the Vithas Medimar hospital a new diagnostic method, the fusion biopsy.

-The fusion of images between MRI and prostate ultrasound has proven to be the best method that we have today to locate alterations of the prostate that could be tumoral and in this way to be able to diagnose them with more precision.

The procedure is ambulatory and painless, it is performed under sedation.

The approach is perineal, avoiding the rectum and therefore the possible infection that can occur in traditional transrectal biopsy.

A new challenge arises in the application of these techniques, being able to detect which of these tumors are really aggressive, that is, those that are going to cause real damage to our body and therefore should be treated with techniques such as surgery or radiotherapy or It is good to rule out those others that, even though they are malignant, are not going to give us problems.

In this way we could avoid unnecessary treatments in those patients who, even though they have prostate cancer, will never pose a danger to the patient’s health or life.

In 30% of men over the age of 50 we can find cancer cells in the prostate but in most cases they will never affect the patient’s quality of life

One of the main challenges of modern oncology is to be able to individualize the treatment of the tumor and for this it is essential to know more about it, its nature and, above all, its capacity to harm the body.

Dr. Bartolomé Lloret

Tel: 965269070

urologist from Hospital Vithas Medimar

Phone: 672377363

Avda. Denia, 78

www.saludhombre.es

#fusion #prostate #biopsy


Share it